The SEBIO Investor Forum is the Southeast region's premier life sciences venture capital conference, connecting emerging life science companies with potential investors in a forum that provides meaningful networking opportunities. Since 1999, Southeast BIO, a regional organization dedicated to promoting the growth of the biotech industry in the Southeastern United States, has presented the annual SEBIO Investor Forum.

Attracting more than 400 attendees, including investors from the Southeast and from around the world, SEBIO showcases more than 30 emerging life sciences companies from Alabama, Florida, Georgia, North Carolina, South Carolina, Tennessee, Virginia, and beyond each year.

Since 1999, 124 venture-backed companies have presented at the Forum, and 82 seed stage companies have participated in the early-stage event. More than $1.2 billion in venture capital funding and $500 million in public offering proceeds has been raised by former SEBIO presenters.

Former SEBIO presenters include Applied Genetic Technologies Corporation; AtheroGenics, Inc.; Biolex, Inc.; Emageon, Inc.; HyperBranch Medical Technology, Inc.; Icagen, Inc.; Inhibitex, Inc.; TransMolecular, Inc.; Tranzyme Pharma, Inc.; and TriVirix.